Changes in osteoporosis therapy in postmenopausal women from the RACOSTPOL study: a 10year followup.
Pol Arch Intern Med
; 132(10)2022 10 21.
Article
em En
| MEDLINE
| ID: mdl-35984953
ABSTRACT
INTRODUCTION:
Therapeutic regimens for osteoporosis are the key elements in the management of osteoporotic patients.OBJECTIVE:
The aim of the study was to present data on changes in osteoporosis therapy in women during a 10year followup. PATIENTS ANDMETHODS:
We analyzed a populationbased sample recruited in the RACOSTPOL study. At baseline, the cohort included 978 women, of whom 541 remained in the followup. Mean (SD) age of the patients was 74.7 (6.6) years.RESULTS:
The number of untreated women and those on alendronate decreased, while the number of patients receiving other forms of the antiresorptive therapy or calcium / vitamin D supplementation increased during the study. The percentage of untreated women in the rural areas and the urban areas was, respectively, 85% and 74.1% at baseline, and 74.3% and 63.3% at the end of the followup. The percentage of untreated women decreased significantly, both in rural and urban cohorts. It was accompanied by a significant increase in calcium / vitamin D supplementation in both subgroups. Regarding the antiresorptive therapy, there was a significant increase in the frequency of its use only in the rural cohort. The use of therapeutic strategies was determined by the level of education. The frequency of calcium and / or vitamin D supplementation increased significantly in all education-related categories during the followup.CONCLUSION:
Changes in the therapy of postmenopausal women with osteoporosis, observed in a 10year followup of the RACOSTPOL study, indicated that the level of care did not improve in this group of patients.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Osteoporose
/
Osteoporose Pós-Menopausa
/
Conservadores da Densidade Óssea
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article